START Physicians

START is comprised of an unparalleled team of physicians and researchers with extensive experience in oncology drug development and patient care.  These researchers have set unprecedented standards for the development of anticancer agents and have contributed to an improved understanding and treatment of cancer as well as the preclinical and clinical development of a number of anti-cancer drugs that are now approved by the FDA.
Dr. Anthony Tolcher, M.D., FRCP(C)

Anthony W. Tolcher, M.D., FRCP(C)

Dr. Anthony W. Tolcher is a co-founder and Director of Clinical Research at START.  He is board-certified in Medical Oncology and Internal Medicine.  He completed medical school in 1986 at the University of British Columbia in Vancouver, Canada.  He completed his residency in Internal Medicine at the University of Toronto and his fellowship in Oncology at the University of British Columbia.  He was a Fogarty Fellow at the National Cancer Institute in Bethesda, Maryland.

 

Amita Patnaik, M.D., FRCP(C)

Amita Patnaik, M.D., FRCP(C)

Dr. Amita Patnaik is a co-founder and Associate Director of Clinical Research at START.  She is board-certified in Medical Oncology. She completed medical school in 1992 at the University of Toronto, in Toronto, Canada.  She completed her residency in Internal Medicine and Medical Oncology at the University of Toronto.  She followed this with research fellowships in Anticancer Drug Development at University of Toronto’s Princess Margaret Hospital in Toronto, Canada and at the CTRC’s Institute for Drug Development in San Antonio, TX.

Kyriakos P. Papadopoulos, M.D.

Kyriakos P. Papadopoulos, M.D.

Dr. Kyriakos P. Papadopoulos is a co-founder and Senior Clinical Investigator at START.  He also serves as START’s co-Director of Pharmacology and Preclinical Research.  He is board-certified in Medical Oncology and Hematology. He completed medical school in 1985 at the University of Witwatersrand, Johannesburg, South Africa and his fellowship in Medical Oncology and Hematology at the College of Physicians and Surgeons of Columbia University, NY.

 

Drew W. Rasco, M.D.

Drew W. Rasco, M.D.

Dr. Drew W. Rasco is a Clinical Investigator at START.  He is board-certified in Internal Medicine.  He completed medical school in 2003 at the University of Texas Health Sciences Center in San Antonio, TX.  He completed his residency in Internal Medicine at the Emory University School of Medicine in Atlanta, GA.  He followed this with fellowships in Hematology and Oncology at the University of Texas Southwestern Medical Center in Dallas, TX.